Alloy vs Winona (2026): HRT Cost, Approach & Who to Choose

Alloy's pricing structure is one of the most transparent in the telehealth HRT space. Programs start around $45/month for estrogen therapy, with combination estrogen-progesterone programs in the $65–$99/month range. These prices reflect FDA-approved generic medications, which have predictable dosing and are often covered partially by insurance.

Winona's pricing starts higher — typically $99–$199/month depending on the hormone combination and delivery form. This reflects the compounded formulation model, which requires custom pharmacy preparation and cannot be partially covered by most insurance plans.

The apparent price gap narrows when insurance is factored in. If your plan covers generic estradiol patches, Alloy's effective monthly cost drops significantly. Winona's compounded programs are fully cash-pay regardless of insurance.

Alloy prescribes FDA-approved bioidentical hormones — specifically, estradiol is bioidentical regardless of whether it is FDA-approved or compounded. The difference is manufacturing source and regulatory oversight, not the molecular structure of the hormone itself.

Winona's compounded formulations allow for non-standard dosages, delivery forms (creams, troches, sublingual drops), and combinations that FDA-approved products don't offer. This can be valuable for women who haven't responded to standard dosing or who need specific combinations.

For most women starting HRT, FDA-approved generics work well and cost less. Compounded formulations make sense when standard options have been tried and more customization is genuinely needed.

Alloy's platform is clean and efficient. The intake process is online, the physician review is typically fast, and the focus is straightforward HRT access without a lot of supplementary services layered on. It's designed for women who know what they need and want a simple, lower-cost path.

Winona has built more of a community and education model around their platform. They publish guides on perimenopause symptoms, have a more consultative intake process, and position themselves as partners in a more personalized hormone journey. This appeals to women who are newer to HRT and want more guidance.

Alloy fits women who want the most cost-effective telehealth HRT access using well-studied FDA-approved medications. If your goal is straightforward estrogen therapy — patches or pills — at the lowest sustainable monthly cost, Alloy's model is hard to beat.

It also works well for women who may have partial insurance coverage for generic medications, since Alloy's prescriptions can be filled at standard pharmacies.

Winona suits women who specifically want compounded bioidentical hormones, need non-standard dosing, or haven't responded well to standard formulations. The more personalized protocol and delivery form flexibility are the genuine value-adds over lower-cost alternatives.

It also fits women who prefer a more educational and supportive platform experience over a purely transactional one — Winona invests more in content and community than Alloy does.